SCHEMBL8522276

SCHEMBL8522276

CCNc1cc(-c2ccc(N)c(NCC)c2)ccc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 1/20 0.44
THRB P10828 1/20 0.44
HTT P42858 1/20 0.44
GFER P55789 1/20 0.44
PLEC Q15149 1/20 0.44
HSD17B10 Q99714 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPK1 P28482 2/20 0.44
POLB P06746 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HDAC2 Q92769 8/20 0.43
HDAC1 Q13547 6/20 0.43
HDAC3 O15379 5/20 0.43
CYP3A4 P08684 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13073879 0.91 HDAC1 (0.57) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL22112765 0.83 LMNA (0.51) LMNAALDH1A1KDM4EMAPTHPGD
Hydrochloric Acid SCHEMBL6852075 0.81 LMNA (0.50) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL2014730 0.81 LMNA (0.50) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL13074267 0.80 HDAC2 (0.62) HDAC2HDAC1HDAC3
SCHEMBL2018693 0.79 LMNA (0.49) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL31708248 0.79 LMNA (0.49) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL14341767 0.79 CYP3A4 (0.63) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL29624972 0.79 LMNA (0.53) LMNAALDH1A1KDM4EMAPTHPGD
SCHEMBL1519088 0.79 LMNA (0.49) LMNAALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0625195-B1 THERAPY OF CENTRAL NERVOUS SYSTEM BY GENETICALLY MODIFIED CELLS UNIV CALIFORNIA (US) 1999-01-07 EP disclosed
US-5762926-A Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-06-09 US disclosed
US-5650148-A Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-07-22 US disclosed
EP-0625195-A1 THERAPY OF CENTRAL NERVOUS SYSTEM BY GENETICALLY MODIFIED CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-11-23 EP disclosed
WO-1993010234-A1 THERAPY OF CENTRAL NERVOUS SYSTEM BY GENETICALLY MODIFIED CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1993-05-27 WO disclosed